Effects of a formula containing two types of prebiotics, bifidogenic growth stimulator and galacto-oligosaccharide, and fermented milk products on intestinal microbiota and antibody response to influenza vaccine in elderly patients: A randomized controlled trial

Pharmaceuticals

Volumn 8, Issue 2, 2015, Pages 351-365

  Nagafuchi, Shinya ^a   Yamaji, Taketo ^a   Kawashima, Akihiro ^a   Saito, Yukiko ^b   Takahashi, Takeshi ^a   Yamamoto, Takayuki ^b   Maruyama, Mitsuo ^c   Akatsu, Hiroyasu ^b,c,d  

^a MEIJI DAIRIES CORPORATION   (Japan)

^b Choju Medical Institute Fukushimura Hospital   (Japan)

^c NATIONAL CENTER FOR GERIATRICS AND GERONTOLOGY   (Japan)

^d NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Bifidobacterium; Enterally fed patients; Hemagglutination inhibition test; Seroprotective rate

Indexed keywords

ALBUMIN; BIFIDOGENIC GROWTH STIMULATOR; CHOLESTEROL; ELECTROLYTE; GALACTOSE OLIGOSACCHARIDE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INFLUENZA VACCINE; MINERAL; PREBIOTIC AGENT; TRANSFERRIN; UNCLASSIFIED DRUG; VITAMIN;

A CALIFORNIA 7 2009 (A H1N1); A VICTORIA 210 2009 (A H3N2); AGED; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; B BRISBANE 60 2008; BACTEROIDES; BIFIDOBACTERIUM; CLINICAL ARTICLE; CLOSTRIDIUM; CLOSTRIDIUM COCCOIDES; CLOSTRIDIUM LEPTUM; CONTROLLED STUDY; ENTERIC FEEDING; ENTEROBACTERIACEAE; ENTEROCOCCUS; FEMALE; FERMENTED PRODUCT; HUMAN; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA B; INTESTINE FLORA; LACTOBACILLUS; MACRONUTRIENT; MALE; MILK; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; RANDOMIZED CONTROLLED TRIAL; VERY ELDERLY; VIRUS STRAIN;

EID: 84935017464     PISSN: None     EISSN: 14248247     Source Type: Journal    
DOI: 10.3390/ph8020351     Document Type: Article

References (31)

1. Fleming, D.M.; Elliot, A.J. The impact of influenza on the health and health care utilisation of elderly people. Vaccine 2005, 23, S1–S9.
2. Nichol, K.L.; Margolis, K.L.; Wuorenma, J.; Von Sternberg, T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. New Engl. J. Med. 1994, 331, 778–784.
3. Vu, T.; Farish, S.; Jenkins, M.; Kelly, H. A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine 2002, 20, 1831–1836.
4. Chen, W.H.; Kozlovsky, B.F.; Effros, R.B.; Grubeck-Loebenstein, B.; Edelman, R.; Sztein, M.B. Vaccination in the elderly: An immunological perspective. Trends Immunol. 2009, 30, 351–359.
5. Vijaya Kumar, S.G.; Singh, S.K.; Goyal, P.; Dilbaghi, N.; Mishra, D.N. Beneficial effects of probiotics and prebiotics on human health. Pharmazie 2005, 60,163–171.
6. Bengmark, S. Use of some pre-, pro- and synbiotics in critically ill patients. Best Pract. Res. Clin. Gastroenterol. 2003, 17, 833–848.
7. Bunout, D.; Barrera, G.; Hirsch, S.; Gattas, V.; de la Maza, M.P.; Haschke, F.; Steenhout, P.; Klassen, P.; Hager, C.; Avendaño, M.; Petermann, M.; Muñoz, C.: Effects of a nutritional supplement on the immune response and cytokine production in free-living Chilean elderly. JPEN J. Parenter. Enteral Nutr. 2004, 28, 348–354.
8. Vos, A.P.; Haarman, M.; van Ginkel, J.W.; Knol, J.; Garssen, J.; Stahl, B.; Boehm, G.; M’Rabet, L. Dietary supplementation of neutral and acidic oligosaccharides enhances Th1-dependent vaccination responses in mice. Pediatr. Allergy Immunol. 2007, 18, 304–312.
9. Boge, T.; Rémigy, M.; Vaudaine, S.; Tanguy, J.; Bourdet-Sicard, R.; van der Werf, S. A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials. Vaccine 2009, 27, 5677–5684.
10. Hojo, K.; Yoda, N.; Tsuchita, H.; Ohtsu, T.; Seki, K.; Taketomo, N.; Murayama, T.; Iino, H. Effect of ingested culture of Propionibacterium freudenreichii ET-3 on fecal microflora and stool frequency in healthy females. Biosci. Microflora 2002, 21, 115–120.
11. Seki, K.; Nakao, H.; Umino, H.; Isshiki, H.; Yoda, N.; Tachihara, R.; Ohuchi, T.; Saruta, H.; Suzuki, K.; Mitsuoka, T. Effects of fermented milk whey containing novel bifidogenic growth stimulator produced by Propionibacterium on fecal bacteria, putrefactive metabolite, defecation frequency and fecal properties in senile volunteers needed serious nursing-care taking enteral nutrition by tube feeding. Chonaisaikingaku zasshi (Japanese) 2004, 18, 107–115.
12. Akatsu, H.; Nagafuchi, S.; Kurihara, R.; Okuda, K.; Kanesaka, T.; Ogawa, N.; Kanematsu, T.; Takasugi, S.; Yamaji, T.; Takami, M, et al. Enhanced vaccination effect against influenza by prebiotics in elder-patients receiving enteral nutrition. Geriatr. Gerontol. Int. 2015. doi:10.1111/ggi.12454.
13. Lesourd, B.M.: Nutrition and immunity in the elderly: Modification of immune responses with nutritional treatments. Am. J. Clin. Nutr. 1997, 66, 478S–484S.
14. Kojimahara, N.; Maeda, A.; Kase, T.; Yamaguchi, N. Cross-reactivity of influenza A (H3N2) hemagglutination-inhibition antibodies induced by an inactivated influenza vaccine. Vaccine 2006, 24, 5966–5969.
15. Scharpé, J.; Peetermans, W.E.; Vanwalleghem, J.; Maes, B.; Bammens, B.; Claes, K.; Osterhaus, A.D.; Vanrenterghem, Y.; Evenepoel, P. Immunogenicity of a standard trivalent influenza vaccine in patients on long-term hemodialysis: An open-label trial. Am. J. Kidney Dis. 2009, 54, 77–85.
16. Matsuki, T.; Watanabe, K.; Fujimoto, J.; Takada, T.; Tanaka, R.: Use of 16S rRNA gene-targeted group-specific primers for real-time PCR analysis of predominant bacteria in human feces. Appl. Environ. Microbiol. 2004, 70, 7220–7228.
17. Dubernet, S.; Desmasures, N.; Guéguen, M. A PCR-based method for identification of lactobacilli at the genus level. FEMS Microbiol. Lett. 2002, 214, 271–275.
18. Artosch, S.; Fite, A.; Macfarlane, G.T.; McMurdo, M.E. Characterization of bacterial communities in feces from healthy elderly volunteers and hospitalized elderly patients by using real-time PCR and effects of antibiotic treatment on the fecal microbiota. Appl. Environ. Microbiol. 2004, 70, 3575–3581.
19. Rinttilä, T.; Kassinen, A.; Malinen, E.; Krogius, L.; Palva, A.: Development of an extensive set of 16S rDNA-targeted primers for quantification of pathogenic and indigenous bacteria in faecal samples by real-time PCR. J. Appl. Microbiol. 2004, 97, 1166–1177.
20. Allsup, S.J.; Shenkin, A.; Gosney, M.A.; Taylor, S.; Taylor, W.; Hammond, M.; Zambon, M.C. Can a short period of micronutrient supplementation in older institutionalized people improve response to influenza vaccine? A randomized controlled trial. J. Am. Geriatr. Soc. 2004, 52, 20–24.
21. Crogan, N.L.; Velasquez, D.; Gagan, M.J. Testing the feasibility and initial effects of iron and vitamin C to enhance nursing home residents’ immune status following an influenza vaccine. Geriatr. Nurs. 2005, 26, 188–194.
22. Moore, S.E.; Goldblatt, D.; Bates, C.J.; Prentice, A.M. Impact of nutritional status on antibody responses to different vaccines in undernourished Gambian children. Acta Paediatr. 2003, 92, 170–176.
23. Benno, Y.; Endo, K.; Mizutani, T.; Namba, Y.; Komori, T.; Mitsuoka, T.: Comparison of fecal microflora of elderly persons in rural and urban areas of Japan. Appl. Environ. Microbiol. 1989, 55, 1100–1105.
24. Tuohy, K.M.; Kolida, S.; Lustenberger, A.M.; Gibson, G.R. The prebiotic effects of biscuits containing partially hydrolysed guar gum and fructo-oligosaccharides—A human volunteer study. Br. J. Nutr. 2001, 86, 341–348.
25. Moro, G.; Arslanoglu, S.; Stahl, B.; Jelinek, J.; Wahn, U.; Boehm, G. A mixture of prebiotic oligosaccharides reduces the incidence of atopic dermatitis during the first six months of age. Arch. Dis. Child. 2006, 91, 814–819.
26. Uchida, M.; Mogami, O.; Matsueda, K. Characteristic of milk whey culture with Propionibacterium freudenreichii ET-3 and its application to the inflammatory bowel disease therapy. Inflammopharmacology 2007, 15, 105–108.
27. Rigon-Zimmer, K.; Mullie, C.; Tir-Touil-Meddah, A.; Buisson, P.; Leke, L.; Canarelli, J.P. Impact of colostomy on intestinal microflora and bacterial translocation in young rats fed with heat-killed Lactobacillus acidophilus strain LB. Folia Microbiol. (Praha) 2008, 53, 89–93.
28. Murasko, D.M.; Bernstein, E.D.; Gardner, E.M.; Gross, P.; Munk, G.; Dran, S.; Abrutyn, E.: Role of humoral and cell-mediated immunity in protection from influenza disease after immunization of healthy elderly. Exp. Gerontol. 2002, 37, 427–439.
29. Goodwin, K.; Viboud, C.; Simonsen, L. Antibody response to influenza vaccination in the elderly: A quantitative review. Vaccine 2006, 24, 1159–1169.
30. Adams, C.A. The probiotic paradox: Live and dead cells are biological response modifiers. Nutr. Res. Rev. 2010, 23, 37–46.
31. Mullié, C.; Yazourh, A.; Thibault, H.; Odou, M.F.; Singer, E.; Kalach, N.; Kremp, O.; Romond, M.B. Increased poliovirus-specific intestinal antibody response coincides with promotion of Bifidobacterium longum-infantis and Bifidobacterium breve in infants: A randomized, double-blind, placebo-controlled trial. Pediatr. Res. 2004, 56, 791–795.